Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19
Status:
Recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
Clinical, control, double-blind, randomized trial with tenofovir disoproxyl fumarate and
emtricitabine for Covid-19
Phase:
N/A
Details
Lead Sponsor:
Universidade Federal do Ceara
Collaborators:
Central Laboratory of Public Health of Ceará - Lacen-CE Conselho Nacional de Desenvolvimento Científico e Tecnológico São José Hospital for Infectious Diseases - HSJ